Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity
Obesity Reviews, Volume 26, Issue 1, January 2025.Summary The rapid and widespread clinical adoption of highly effective incretin‐mimetic drugs (IMDs), particularly semaglutide and tirzepatide, for the treatment of obesity has outpaced the updating of clinical practice guidelines. Consequently, many patients may be at risk for adverse effects and uncertain long‐term outcomes related to the use of ...
Jeffrey I. Mechanick +6 more
wiley +1 more source
Risk factors for 5-year mortality in a cohort of elderly patients with sarcopenia [PDF]
, 2020 Background: The association between multiple risk factors and the mortality of sarcopenic patients has not been studied. This study's aim is to report the prevalence of sarcopenia among a sample of Italian hospitalized older adults, describe the physical
Abbas H. +10 more
core +1 more source
Osteosarcopenia and Pain: Do We Have a Way Out? [PDF]
, 2023 osteosarcopenia (OSP) is a geriatric syndrome characterized by the coexistence of osteoporosis and sarcopenia and associated with an increased risk of fragility fractures, disability, and mortality.
Bonanni, Roberto +7 more
core +1 more source
Exploring the Relationship Between Gut Microbiota and Sarcopenia Based on Gut–Muscle Axis
Food Science &Nutrition, Volume 12, Issue 11, Page 8779-8792, November 2024.This review summarizes the role and impacts of gut microbiota on the muscle, the relevance between gut microbiota and sarcopenia, potential mechanisms of gut microbiota in the modulation of sarcopenia, potential methods to alleviate sarcopenia by modulating gut microbiota, and relevant advances and perspectives, thus contributing to adding more novel ...
Wei Li +3 more
wiley +1 more source
Sarcopenic obesity, pathogenesis, and treatment with a focus on exercise and protein intake [PDF]
, 2023 Sarcopenic obesity involves the co-occurrence of sarcopenia and obesity, yields more health risks than either condition alone, thus requiring prevention and treatment for healthy aging.
Karaağaç, Yasemin
core +2 more sources
Behavioral weight loss interventions for people with physical disabilities: A systematic review
Obesity Reviews, Volume 25, Issue 6, June 2024.Summary Aim The aim of this study is to examine which interventions lead to clinically significant weight loss among people with physical disabilities. Methods We systematically searched three electronic databases (PubMed, Scopus, and CENTRAL) including studies until May 2022 to find randomized controlled trials on behavioral interventions and weight ...
Jihad Hossaini +2 more
wiley +1 more source
Prevention and Treatment of Sarcopenic Obesity in Women [PDF]
, 2019 Sarcopenic obesity (SO) is referred to as the combination of obesity with low skeletal muscle mass and function. However, its definition and diagnosis is debated.
Bazzocchi A. +5 more
core +1 more source
Osteosarcopenia: epidemiology, diagnosis, and treatment—facts and numbers
Journal of Cachexia, Sarcopenia and Muscle, 2020 Background Osteosarcopenia, the presence of osteopenia/osteoporosis and sarcopenia, is an emerging geriatric giant, which poses a serious global health burden.
Ben Kirk, Jesse Zanker, Gustavo Duque
doaj +1 more source
Review on understanding of Astha Sthoulya Doshas and Sthoulya Lakshanas [PDF]
Sthoulya is one among Santarpanotta Vikara and it is caused by Kapha Pradhana and Medodhushti. All the Santarponotta Nidanas and Medodhushti which will lead for Sthoulya.
Mahesh Hirulal, Vardhaman Iraj
core +2 more sources
Racial/ethnic differences in bone mineral density, muscle function and fat mass in young women [PDF]
, 2019 Background: Racial/ethnic differences in bone mineral density(BMD) result in increased susceptibility of some ethnic groupsto fragility fractures in comparison to others.
Bemben, Debra +4 more
core +1 more source